Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MRSN Mersana Therapeutics

7.090
+0.670+10.44%
Close 10/04 16:00 ET
High
7.090
Open
6.510
Turnover
7.31M
Low
6.400
Pre Close
6.420
Volume
1.06M
Market Cap
688.93M
P/E(TTM)
Loss
52wk High
10.010
Shares
97.17M
P/E(Static)
Loss
52wk Low
2.680
Float Cap
500.59M
Bid/Ask %
98.20%
Historical High
29.090
Shs Float
70.60M
Volume Ratio
0.78
Historical Low
1.320
Dividend TTM
--
Div Yield TTM
--
P/B
5.14
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.51%
Amplitude
10.75%
Avg Price
6.873
Lot Size
1
Float Cap
500.59M
Bid/Ask %
98.20%
Historical High
29.090
Shs Float
70.60M
Volume Ratio
0.78
Historical Low
1.320
Dividend TTM
--
P/B
5.14
Dividend LFY
--
Turnover Ratio
1.51%
Amplitude
10.75%
Avg Price
6.873
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing antibody drug conjugates that offer clinical benefit for cancer patients with significant unmet need. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA.
CEO: Ms. Anna Protopapas
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...